Iterum Therapeutics (ITRM.Q) announced today that it has received a Complete Response Letter (CRL) from the US Food and Drug Administration (FDA) for its New Drug Application (NDA). Iterum…
Latest News
Top 5 Gainers and Losers: RPX.V, NINE.CN, DCBO.TO
Silver bulls maintain strong uptrend!
Top 5 Gainers and Losers: WIFI.CN, RAIL.CN, BHS.V
Standard Uranium (STND.V) begins inaugural drill program at Canary Project
Top 5 Gainers and Losers: SHOP.TO, MNO.TO, EFX.TO
Good Guy Wrap: Who’s moving up, who’s good value, who you should burn